하이텍팜

106190KOSDAQ기초 의약물질 제조업

60.5 / 100

Reference Date: 2026-07-24

Financial Score31.0 / 40

News Sentiment12.5 / 25

Momentum7.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but Revenue is on a declining trend. Plunged 20.5% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Hitek Pharm is a specialized pharmaceutical company established in 1998, focusing on carbapenem-class antibiotic APIs. Its flagship products, imipenem and ertapenem, leverage strong antibacterial properties and high price competitiveness, with exports accounting for 99.99% of sales, primarily to Europe and Asia. In 2023, the company achieved sales of 77.5 billion KRW and operating profit of 15.56 billion KRW, demonstrating sustained growth.

Number of Employees

130people

Average Salary

59.1M KRW

Score Calculation Basis

Detailed Financial Score

PER

9.97Industry Average 25.448.0Point

Half of industry avg (excellent)

PBR

0.88Industry Average 1.265.5Point

Lower than industry avg (good)

ROE

9.17Industry Average -6.033.5Point

Well below industry avg

Debt Ratio

0.39Industry Average 6.628.0Point

Half of industry avg (excellent)

Trend 2023~20256.0 / 10 points

Revenue Growth Rate

0.5 / 3

Avg ▼4.2% (2-year basis)

Operating Profit Growth Rate

2.5 / 3

Avg ▲18.4% (2-year basis)

ROE Trend

3.0 / 4

Avg ROE 9.7% (improving, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (2%, downtrend)

Current 10,760Won52-week high 25,00052-week low 10,340

1-month return0.0Point

1m -20.47% (strong drop)

Volume trend6.0Point

Volume increasing

Detailed Disclosure

0 totalPositive 0Neutral 0Negative 0